Episode 3: Opeyemi Olabisi on APOL1-Mediated Kidney Disease and Community Engagement

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/e0/58/cb/e058cbf0-9855-ef9f-a05c-afbb3a08a669/mza_10772323051527990381.jpg/600x600bb.jpg

GN in Ten

International Society of Glomerular Disease

13 episodes

3 weeks ago

A bite-size podcast brought to you by the International Society of Glomerular Disease. Nephrologists and glomerular disease experts Dr. Kenar Jhaveri (Northwell Health/Hofstra University) and Dr. Koyal Jain (UNC Chapel Hill) take a lighthearted look at the latest research, discuss clinical practice, and interview leaders in glomerular medicine — all in a short enough time to listen on your coffee break.

All content for GN in Ten is the property of International Society of Glomerular Disease and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Episode 3: Opeyemi Olabisi on APOL1-Mediated Kidney Disease and Community Engagement

GN in Ten

15 minutes

1 year ago

Episode 3: Opeyemi Olabisi on APOL1-Mediated Kidney Disease and Community Engagement

We talk with Dr. Opeyemi Olabisi, MD, PhD, about the history and future of APOL1-mediated FSGS, the role of clinical researchers in building trust with patients, his innovative CARE and JUSTICE programs to bring kidney health screenings and research opportunities to the underrepresented African American community, and why his expertise as an MD/PhD in molecular biology led him to also become a leader in community engagement. The JAK-STAT pathway gets some love as well!

Dr. Olabisi's research and publications: https://medicine.duke.edu/profile/opeyemi-olabisi
More information on the CARE and JUSTICE studies: https://kidneycareandjustice.com/

Disclosures: Dr. Olabisi reports receiving research funding from NIH and Icagen, and consulting for Maze Therapeutics and Podium Bio.